GEORGE NOON to Ventricular Remodeling
This is a "connection" page, showing publications GEORGE NOON has written about Ventricular Remodeling.
Connection Strength
0.474
-
Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart. J Surg Res. 2007 Jun 15; 140(2):199-203.
Score: 0.266
-
Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling. J Heart Lung Transplant. 2007 Jan; 26(1):34-40.
Score: 0.065
-
The response of the failing heart to chronic mechanical unloading. Curr Opin Cardiol. 2004 May; 19(3):270-7.
Score: 0.054
-
New surgical therapies for heart failure. Curr Opin Cardiol. 2003 May; 18(3):194-8.
Score: 0.051
-
Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol. 2004 Mar 03; 43(5):811-7.
Score: 0.013
-
Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy. J Heart Lung Transplant. 2004 Jan; 23(1):28-35.
Score: 0.013
-
Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet. 2002 Mar 16; 359(9310):936-41.
Score: 0.012